Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation

BACKGROUND: Liver cirrhotic patients with nonvalvular atrial fibrillation have been excluded from randomized clinical studies regarding oral anticoagulants for stroke prevention. Whether non–vitamin K antagonist oral anticoagulants (NOACs) are superior to warfarin for these patients remains unclear....

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hsin‐Fu, Chan, Yi‐Hsin, Chang, Shang‐Hung, Tu, Hui‐Tzu, Chen, Shao‐Wei, Yeh, Yung‐Hsin, Wu, Lung‐Sheng, Kuo, Chang‐Fu, Kuo, Chi‐Tai, See, Lai‐Chu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474939/
https://www.ncbi.nlm.nih.gov/pubmed/30834802
http://dx.doi.org/10.1161/JAHA.118.011112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474939/
https://www.ncbi.nlm.nih.gov/pubmed/30834802
http://dx.doi.org/10.1161/JAHA.118.011112

Ejemplares similares